Monday, 20 October 2014   
Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer
Researchers at VTT Technical Research Centre of Finland, the University of Turku and the University of Oslo have discovered a previously unknown molecular-level mechanism that may partly explain the increased growth of cancer cells. The study, published in the British Journal of Cancer, showed that high levels of miRNA-378a-5p molecule cause cell division anomalies. This renders the number of chromosomes in cancer cells abnormal, which is known to promote growth and the spread of cancer.
 
Thursday, 16 October 2014   
Novalik-Pharm and Pharmplanet signed international manufacturing contracts
Ukrainian pharmaceutical company Novalik-Pharm and its official distributor Pharmplanet took part in the international exhibition in Paris. This year, CPhI Worldwide celebrates its 25th anniversary. Specifically to this date the organizers arranged a competition "Top 25 Success Stories". According to the decision of the jury, Pharmplanet was included in the list of 25 most successful pharmaceutical world's companies for most dynamic development of the market.
 
Tuesday, 14 October 2014   
4th European Code Against Cancer launched today
Today sees the launch of an updated European Code Against Cancer - the fourth edition of the Code since its creation in 1987. With the knowledge that the risk of having cancer can, to a certain extent, be reduced by adopting healthier lifestyles, and outcomes greatly improved if cancer is detected early on, the Code aims to arm citizens with key information through its 12 recommendations.
 

Research & Development

Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer

Researchers at VTT Technical Research Centre of Finland, the University of Turku and the University of Oslo have discovered a...

Novalik-Pharm and Pharmplanet signed international manufacturing contracts

Ukrainian pharmaceutical company Novalik-Pharm and its official distributor Pharmplanet took part in the international exhibition in Paris. This year, CPhI...

4th European Code Against Cancer launched today

Today sees the launch of an updated European Code Against Cancer - the fourth edition of the Code since its...

Nanoparticle research could enhance drug delivery through skin

Scientists at the University of Southampton have identified key characteristics that enhance a nanoparticle's ability to penetrate skin, in a...

More in: Research & Development

Conferences & Events

mHealth Summit Europe 2015 and eHealth Week join forces

11 - 12 May 2015, Riga, Latvia. The mHealth Summit Europe will be back in 2015 as a part of eHealth Week in Riga, Latvia. The Summit will be opening...

European Telemedicine Conference 2014

7 - 8 October 2014, Rome, Italy. The European Telemedicine Conference (ETC) 2014 will combine the efforts of several leading European Healthcare Organisations into one powerful event. The conference will...

Medical Entrepreneur Start-up Hospital - M.E.S.H Camp 2014

17 - 18 September 2014, Berlin, Germany. Anyone who's ever tried to launch a start-up knows how hard it is. It takes all you've got to succeed. DocCheck Guano organises...

Biovision presents its selection of 44 promising life sciences businesses and projects

5 - 6 June 2014, Lyon, France. Biovision, the annual forum on future-oriented research in life sciences, today announces the list of biotech and medtech companies and projects selected for...

Delegates from more than 30 countries to share the benefits of eHealth at WoHIT 2014

2 - 4 April 2014, Nice, France. The World of Health IT Conference and Exhibition 2014 (WoHIT 2014), taking place in Nice, France, presents a comprehensive international programme with 18...

More in: Conferences & Events

EC Pharmaceuticals

Medicines for children: more research, more availability and more information compared with 5 years ago

News image

Recently, the Commission has publisheed a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in...

New symbol to identify medicines undergoing additional monitoring

News image

An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a legal act adopted by the European Commission today. The symbol...

Launch of EU Rapid Alert platform for human Tissues and Cells

News image

A secure alert platform launched by the European Commission will improve the safety of patients undergoing transplantation and medical procedures involving human tissues and cells, e.g. bone marrow, cornea, skin,...

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

More in: European Commission

EMA News

Europe to boost cooperation with international partners on generics

News image

The European Union's decentralised procedure is being used as a model to accelerate the assessment of applications for generic medicines as part of the International Generic Drug Regulators Pilot(IGDRP). The...

European Medicines Agency recommends 39 medicines for human use for marketing authorisation in first half of 2014

News image

Thirty-nine medicines for human use were recommended for marketing authorisation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared...

EMA publishes 2013 annual report

News image

The European Medicines Agency (EMA) has published today its 2013 annual report. In 2013, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for human use...

Committee for orphan medicines - overview of 2013 and looking ahead

News image

A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2013 were intended...

More in: EMA